Practice question

Answer the question and get instant feedback.

HardNeurologyParkinson's Disease Managementmrcp part 1ukmlaprescribing safety assessment

A 65-year-old man with Parkinson's disease, treated with co-careldopa, develops worsening motor fluctuations with significant 'off' periods. His neurologist is considering adding an additional medication. Which of the following adjunct medications acts by inhibiting the peripheral breakdown of levodopa, thereby increasing its bioavailability and prolonging its effect?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.